Mitophagy is an evolutionarily conserved process involving the autophagic targeting and clearance of mitochondria destined for removal. Recent insights into the complex nature of the overlapping pathways regulating mitophagy illustrate mitophagy’s essential role in maintaining the health of the mitochondrial network. In this review, we highlight recent studies that have changed the way mitophagy is understood, from initiation through lysosomal degradation. We outline the numerous mitophagic receptors and triggers, with a focus on basal and physiologically relevant cues, offering insight into why they lead to mitochondrial removal. We also explore how mitophagy maintains mitochondrial homeostasis at the organ and system levels and how a loss of mitophagy may play a role in a diverse group of diseases, including cardiovascular, metabolic, and neurodegenerative diseases. With disrupted mitophagy affecting such a wide array of physiological processes, a deeper understanding of how to modulate mitophagy could provide avenues for numerous therapies.
Skip Nav Destination
Close
Article navigation
2 November 2020
Review|
September 14 2020
Mitophagy pathways in health and disease
Samuel A. Killackey
,
1
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
Correspondence to Samuel A. Killackey: sam.killackey@mail.utoronto.ca
Search for other works by this author on:
Dana J. Philpott
,
Dana J. Philpott
2
Department of Immunology, University of Toronto, Toronto, Ontario, Canada
Search for other works by this author on:
Stephen E. Girardin
1
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
2
Department of Immunology, University of Toronto, Toronto, Ontario, Canada
Stephen E. Girardin: stephen.girardin@utoronto.ca
Search for other works by this author on:
Samuel A. Killackey
1
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
Dana J. Philpott
2
Department of Immunology, University of Toronto, Toronto, Ontario, Canada
Stephen E. Girardin
1
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
2
Department of Immunology, University of Toronto, Toronto, Ontario, Canada
Correspondence to Samuel A. Killackey: sam.killackey@mail.utoronto.ca
Stephen E. Girardin: stephen.girardin@utoronto.ca
Received:
June 05 2020
Revision Received:
August 12 2020
Accepted:
August 13 2020
Online Issn: 1540-8140
Print Issn: 0021-9525
Funding:
Canadian Institutes of Health Research
(000303157)
© 2020 Killackey et al.
2020
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
J Cell Biol (2020) 219 (11): e202004029.
Article history
Received:
June 05 2020
Revision Received:
August 12 2020
Accepted:
August 13 2020
Citation
Samuel A. Killackey, Dana J. Philpott, Stephen E. Girardin; Mitophagy pathways in health and disease. J Cell Biol 2 November 2020; 219 (11): e202004029. doi: https://doi.org/10.1083/jcb.202004029
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Advertisement
Advertisement